All In MedTech

Device Trial Radar · NCT01728103

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

Prospective Collection of Female First-catch Urine, Vaginal Swab,Cervical, and Endocervical Swab Specimens for Testing With the APTIMA Assays

Last checked: Nov 19, 2026Latest source record: Aug 16, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

1,336

Actual

Start

Jan 2013

Primary completion

Jul 2014

Sponsor

Lead sponsor
Gen-Probe, IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Nov 16, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
Female only, from 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to obtain female first-catch urine, vaginal, cervical and endocervical swabs for testing with multiple APTIMA Assays on the Gen-Probe PANTHER® and TIGRIS® Systems.

Conditions

  • Chlamydia Infections
  • Gonorrhea
  • Trichomonas Infections

Interventions

  • APTIMA® Trichomonas vaginalis & APTIMA® COMBO 2® AssaysDevice

    In Vitro Diagnostic Assays

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Qualitative detection of ribosomal RNA from Chlamydia trachomatis and/or Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) to aid in the diagnosis of chlamydial and/or gonococcal and/or trichomonal urogenital diseaseTime frame: approximately one year

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Infectious Diseases STD Program University of Alabama at Birmingham

    Birmingham, Alabama

  • Medical Center for Clinical Research

    San Diego, California

  • Healthcare Clinical Data

    North Miami, Florida

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.